Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sofosbuvir + Velpatasvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05AP
- Strength
- 400 mg + 100 mg
- Dosage form
- Tablet
- Pack
- 7's
- Registration no.
- 092795
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-10 03:32
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Vesoft 400 mg + 100 mg tablet
Vesoft 400 mg + 100 mg tablet contains Sofosbuvir + Velpatasvir 400 mg + 100 mg. It is registered with DRAP by HIGH-Q Pharmaceuticals (registration no. 092795). Its official price is PKR 4,907.15 for a pack of 7's, about PKR 701.02 per tablet. This price has applied since 18 August 2025. It is sold in 3 pack sizes: 7's, 14's and 28's. 19 other brands of Sofosbuvir + Velpatasvir 400 mg + 100 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Vesoft 400 mg + 100 mg pack sizes and prices
All 19 other brands of Sofosbuvir + Velpatasvir 400 mg + 100 mg tablet in Pakistan
Sorted by price per tablet, lowest first. The lowest is Cure-C Forte (Global Pharmaceuticals (Pvt.) Ltd) at PKR 443 per tablet; the highest is Velso 400mg at PKR 736. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Cure-C Forte | Global Pharmaceuticals (Pvt.) Ltd | 28's | PKR 12,392.20 | PKR 443 / tablet |
| VSOF 400 | Wilshire Laboratories (Private) Limited | 14s | PKR 7,063.35 | PKR 505 / tablet |
| VSOF | Wilshire Laboratories (Private) Limited | 28s | PKR 14,126.70 | PKR 505 / tablet |
| Sofonil Plus | NovaMed Pharmaceuticals(Pvt.)Ltd | 14's | PKR 8,028.63 | PKR 573 / tablet |
| Fosbu V | Highnoon Laboratories Ltd | 28 | PKR 16,057.26 | PKR 573 / tablet |
| Hepgard-V | Barrett Hodgson Pakistan (Pvt.) Ltd | 28's | PKR 17,235.87 | PKR 616 / tablet |
| Wilpat | Wilson's Pharmaceuticals | 14's | PKR 9,232.93 | PKR 659 / tablet |
| Werya | Werrick Pharmaceuticals | 14's | PKR 9,232.93 | PKR 659 / tablet |
| Sovela | The Searle Company Limited | 28’s | PKR 19,414.64 | PKR 693 / tablet |
| Bosovel | Bosch Pharmaceuticals (Pvt) Ltd | 28's | PKR 19,415.00 | PKR 693 / tablet |
| ABRIVA PLUS | CCL Pharmaceuticals (Pvt.) Limited | 28's | PKR 19,821.25 | PKR 708 / tablet |
| Dowvir | Martin Dow Limited | 28's | PKR 19,821.26 | PKR 708 / tablet |
| VIBRENTA-VPT 400mg | TABROS PHARMA (PVT). LTD | 28'S | PKR 19,945.06 | PKR 712 / tablet |
| OCVIR-V | SAMI Pharmaceuticals Pvt. Ltd | 28's | PKR 19,947.37 | PKR 712 / tablet |
| Maclusa | Macter International Limited | 28's | PKR 20,176.07 | PKR 721 / tablet |
| HILVEL 400mg | Hilton Pharma (Pvt) Limited | 28's | PKR 20,364.34 | PKR 727 / tablet |
| Velso | M/s. Genix Pharma (Pvt) Ltd | 14's | PKR 10,299.11 | PKR 736 / tablet |
| Velpaget | Getz Pharma (Pvt) Limited | 28's | PKR 20,598.23 | PKR 736 / tablet |
| Velso 400mg | M/s. Genix Pharma (Pvt) Ltd | 7's | PKR 5,149.56 | PKR 736 / tablet |
Official price over time
No change in the official DRAP price is recorded for this pack (7's). Current price PKR 4,907.15, effective 18 Aug 2025.
Cite this price history
MedInfoBase. Vesoft 400 mg + 100 mg, 7's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/vesoft-400-mg-100-mg-092795-14s-high-q-pharmaceuticals/ (accessed 10 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 4,907.15 | 2025-08-18 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 092795Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
